检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
机构地区:[1]宜宾学院医院,四川宜宾644007 [2]宜宾学院化学与化工学院,四川宜宾644007 [3]川北医学院临床医学院,四川南充637000
出 处:《中国现代医学杂志》2011年第27期3396-3399,共4页China Journal of Modern Medicine
基 金:宜宾学院青年基金项目(No:2010Q11);四川省青年科技基金(No:09ZQ026-066);宜宾学院科研与教学创新团队建设计划(No:Cx201104)
摘 要:目的探讨血、尿白细胞介素-6(IL-6)的检测在重症狼疮肾炎(SLN)患者中的临床价值。方法采用双抗体夹心ELISA法检测38名健康人(正常对照组)和43例SLN患者经甲泼尼龙(MP)与环磷酰胺(CTX)双冲击治疗前后血、尿IL-6的水平;抗双链DNA抗体、抗核小体抗体采用ELISA法测定;抗核抗体采用间接免疫荧光法检测;补体C3、C4含量采用速率散射比浊法测定。结果 SLN患者治疗前血、尿IL-6的水平均显著高于正常对照组(P<0.01)并与SLEDAI评分、抗核抗体、抗双链DNA抗体、抗核小体抗体、血沉、24 h小时尿蛋白定量、血尿素氮(BUN)、血肌酐(Scr)、尿胱抑素C呈显著正相关(P<0.05或<0.01),与补体C3、C4、内生肌酐清除率(Ccr)呈显著负相关(P<0.05或<0.01);但血清IL-6与尿IL-6无相关关系(P>0.05)。MP与CTX双冲击治疗能显著降低SLN患者血、尿IL-6的水平(P<0.01)。结论 IL-6参与了SLN的发病过程,血、尿IL-6水平的检测在一定程度上可反映SLN患者肾脏损害程度、病情轻重。动态观察SLN患者血、尿IL-6的水平有助于了解SLN的狼疮活动、治疗效果及判断预后。[ Objective ] To investigate the clinical value of detecting serum and urine IL-6 on patients with severe lupus nephritis (SLN). [Methods] Serum and urine IL-6 levels were determined in 38 health controls and 43 cases of SLN patients by double antibody sandwich enzyme-linked immunosorbent assay (ELISA) before and after the double pulse therapy with MP and CTX. Anti-dsDNA antibody and Anti-nucleosome antibodies antibody were detected by ELISA. Antinuelear antibody (ANA) was detected by indirect immunofluorescence. Complement C3 and complement C4 were detected by rate nephelometry. [Results] The levels of serum and urine IL-6 were significantly higher in SLN than those in normal control group (P 〈0.01) and they were positively correlated with the systemic lupus erythematosus disease activity index (SLEDA1) score, ANA, anti-dsDNA antibody, Anti-nucleosome antibody(AnuA), erythroeyte sedimentation rate (ESR), 24-hour urinary protein, blood urea nitrogen (BUN), serum creatinine (Ser) and cystatin C (Cyst C)(P 〈0.05 or 19 〈0.01), and negatively correlated with complement C3, complement C4 and endogenous creatinine clearance rate (Ccr)(P 〈0.05 or P 〈0.01). But there was no correlation between serum IL-6 level and urine IL-6 level(P 〉0.05). In patients with SLN treated with the double pulse therapy with MP and CTX, the levels of serum and urine IL-6 were obviously lower than those of pre-treatment (P 〈0.01). [ Conclusions ] IL-6 takes part in the progress of SLN. The level of serum and urine IL-6, in some degree, indicates the level of renal damage and the extent of the disease with SLN. The dynamic observation of the level of serum and urine IL-6 contributes to judge SLN'S activity, treatment effectiveness and prognosis.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.227